Cyclopenthiazide
CAS No. 742-20-1
Cyclopenthiazide( Cyclomethiazide | Su-8341 | SU 8341 )
Catalog No. M24749 CAS No. 742-20-1
Cyclopenthiazide is a thiazide diuretic used to treat hypertension and heart failure. It decreases the excretion of calcium ions and uric acid and increases the excretion of sodium and potassium ions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 61 | In Stock |
|
| 5MG | 88 | In Stock |
|
| 10MG | 128 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 407 | In Stock |
|
| 100MG | 599 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameCyclopenthiazide
-
NoteResearch use only, not for human use.
-
Brief DescriptionCyclopenthiazide is a thiazide diuretic used to treat hypertension and heart failure. It decreases the excretion of calcium ions and uric acid and increases the excretion of sodium and potassium ions.
-
DescriptionCyclopenthiazide is a thiazide diuretic used to treat hypertension and heart failure. It decreases the excretion of calcium ions and uric acid and increases the excretion of sodium and potassium ions.(In Vivo):Cyclopenthiazide (0.5 mg/kg; i.p.; daily, for 3 days; female Wistar rats) increases the excretion of p-aminohippurate (PAH) .
-
In Vitro——
-
In VivoCyclopenthiazide (0.5 mg/kg; i.p.; daily, for 3 days; female Wistar rats) increases the excretion of p-aminohippurate (PAH) . Animal Model:Female Wistar rats Dosage:0.5 mg/kg Administration:Intraperitoneal injection; daily, for 3 daysResult:Stimulated p-aminohippurate (PAH) excretion.
-
SynonymsCyclomethiazide | Su-8341 | SU 8341
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number742-20-1
-
Formula Weight379.88
-
Molecular FormulaC13H18ClN3O4S2
-
Purity>98% (HPLC)
-
SolubilityDMSO:Soluble; Water:Insoluble
-
SMILESNS(c(cc(c(NC(CC1CCCC1)N1)c2)S1(=O)=O)c2Cl)(=O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Krum H, Jackson B, Conway EL, Howes LG, Johnston CI, Louis WJ. Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide. J Cardiovasc Pharmacol. 1992 Sep;20(3):451-7. PubMed PMID: 1279292.
molnova catalog
related products
-
Anti-Kentsin
Anti-Kentsin
-
VT-105
VT-105 is a potent and selective TEAD autopalmitoylation inhibitor that hinders proliferation and tumor growth in NF2-deficient mesotheliomas.
-
2B/3, Dengue Proteas...
2B/3, Dengue Protease Substrate
Cart
sales@molnova.com